Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The patient (or their legal representative) has signed a consent form, and the investigator considers the patient able to participate and complete study questionnaires.
- Adults aged 18 years or older.
- People diagnosed with a moderate-to-severe level of heart failure (called NYHA Class III), meaning they experience breathlessness with mild physical activity, regardless of how well the heart pumps.
- People who experienced a serious episode of heart failure called cardiogenic shock during a current hospital stay — where blood pressure dropped dangerously low or required special medications to keep it stable, along with signs that organs were affected (such as fluid in the lungs, confusion, very low urine output, or abnormal blood test results) — and who survived to be discharged from hospital.
- People who have access to the internet and a phone, so that the implanted device can communicate with the research team.
Who may not be able to join:
- People for whom the procedure would carry an unusually high risk, based on the investigator's assessment.
- People who are already using a long-term mechanical heart support device (such as a permanent heart pump), or who received a heart transplant during the same hospital stay for cardiogenic shock.
- People who are pregnant (confirmed by a positive pregnancy test), if there is a possibility of pregnancy.
- People who are transitioning to hospice or end-of-life care.
- People who are unable to tolerate or are unlikely to be able to take anti-clotting medication consistently for one year after the device is implanted.
- People who have an active infection that is not under control.
- People who have another medical condition (separate from heart failure) that may limit survival to less than 6 months.
- People being discharged somewhere other than an acute rehabilitation facility or returning home.
- People without access to the internet or a phone.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Shashank Sinha, MD MSc, Inova Fairfax Medical Campus
Phone: 7037764001
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Hierarchical primary endpoint
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.